Organon & Co.

Organon & Co. is a global healthcare company formed in 2021 through a spin-off from Merck & Co., focusing primarily on women's health, biosimilars, and established brands. While the company maintains an office in Oss, Netherlands, it is headquartered in Jersey City, New Jersey, and operates as a publicly traded company on the New York Stock Exchange.